Aeolian Biotech to Present at the 2023 BIO CEO & Investor Conference
01 Feb 2023
Vaccine
LINCOLN, Neb.--(BUSINESS WIRE)-- Aeolian Biotech Corp. today announced that Tyler Martin, M.D., Chief Executive Officer of Aeolian, will present a Company overview at the BIO CEO & Investor Conference on Monday, February 6, 2023 at 10:15 am ET. The conference is being held at the New York Marriott Marquis in New York City, February 6-7, 2023. Investors interested in arranging a meeting with company management can do so as registered conference participants through the BIO CEO & Investor Conference website at or by emailing Ian Frost at Ian.Frost@Westwicke.com.
Aeolian’s presentation may be accessed from the Company's website at .
About Aeolian Biotech Corp.
Aeolian is committed to the development of an improved pneumococcal conjugate vaccine to address the threat of circulating and emerging pneumococcal serotypes.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.